Annual report pursuant to Section 13 and 15(d)

Note 11 - Segment Information (Details Textual)

v3.10.0.1
Note 11 - Segment Information (Details Textual)
12 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Number of Reportable Segments 3  
Customer Concentration Risk [Member] | Sales Revenue, Segment [Member] | Biotechnology [Member]    
Number of Major Customers 0  
Customer Concentration Risk [Member] | Sales Revenue, Segment [Member] | Protein Platforms [Member]    
Number of Major Customers 0  
Customer Concentration Risk [Member] | Sales Revenue, Segment [Member] | Diagnostics [Member]    
Number of Major Customers 0  
Customer Concentration Risk [Member] | Sales Revenue, Segment [Member] | Diagnostics [Member] | One Customer [Member]    
Concentration Risk, Percentage   12.00%